Biotechnological Management of Angiopathic Wounds: Challenges and Perspectives. (December 2018)

• Record Type: Journal Article
• Authors: Jiang, Yufeng; Li, Meirong; Fu, Xiaobing
• Other Names: Papi Massimo guest-editor.; Rerkasem Kittipan guest-editor.
• Is Part Of: International journal of lower extremity wounds. Volume 17:Number 4(2018:Dec.)
• Page Start: 214
• Page End: 217
• Publication Date: 2018-12
• Subjects: angiopathic wounds -- biotechnological management -- chronic wounds; Leg -- Wounds and injuries -- Periodicals; Wounds and injuries -- Prevention -- Periodicals; Leg -- Ulcers -- Periodicals; Wound healing -- Periodicals; 617.584
• DOI: 10.1177/1534734618813232
• Languages: English
• ISSNs: 1534-7346

Abstract

Angiopathic wound is a wound that develops as a result of a local vascular lesion. Angiogenesis is an important aspect underlying repair, and increased angiogenesis could accelerate and improve the healing outcome. Biotherapy has been used more and more in clinic and brings hope for angiopathic wound treatment, through the rapid recovery of angiogenesis and regulation and correction of the whole wound microenvironment. In this article, we discuss the advantages and disadvantages of various technologies ranging from presentation of angiogenic growth factors, genetic strategies, stem cells, and biomaterials engineering in angiopathic wound treatment.